A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma

MeSH terms

• Aged
• Aged, 80 and over
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / adverse effects
• Antineoplastic Agents / therapeutic use*
• Arsenicals / administration & dosage
• Arsenicals / adverse effects
• Arsenicals / therapeutic use*
• Female
• Glutathione / administration & dosage
• Glutathione / adverse effects
• Glutathione / analogs & derivatives*
• Glutathione / therapeutic use
• Hodgkin Disease / drug therapy*
• Humans
• Lymphoma, Non-Hodgkin / drug therapy*
• Male
• Middle Aged
• Recurrence
• Treatment Outcome